$0.45

0.00 (0.04%)

10/10/2008 3:59 PM

Angiotech Pharmaceuticals, Inc. (USA) (ANPI)

CAPS Rating:

A specialty pharmaceutical and medical device company that discovers, develops and markets innovative technologies and medical products for local diseases, and for other complications.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

ANPI doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

164 Outperforms

18 Underperforms

All-Stars

40 Outperforms

8 Underperforms

Wall Street

4 Outperforms

0 Underperforms

Members bullish on ANPI are also bullish on:

Members bearish on ANPI are also bearish on:

Ticker Tags

Drug Manufacturers - Other (105), Micro Cap (4824)
Suggest a tag

Angiotech Pharmaceuticals, Inc. (USA) At A Glance

Current Price:	$0.45
Last Trade Time:	10/10/2008 3:59 PM
Open:	$0.45
Previous Close:	$0.45
Daily Range:	$0.41 - $0.46
52-Week Range:	$0.40 - $7.90
Volume:	619,364
Market Cap:	$38.30M
P/E Ratio:	50.62
Compare Our Special Broker Offers!

Stock Trends

ANPI VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for ANPI

Angiotech due to collect royalties on stent
10/10/2008 5:27:00 PM - AP
CombinatoRx 2Q loss grows on higher research costs
8/6/2008 10:33:00 AM - AP
Earnings roundup: Angiotech, Plum Creek Timber
7/28/2008 7:56:00 PM - AP
Angiotech posts wider 2Q loss on research costs
7/28/2008 2:43:00 PM - AP

More Headlines...

Top Bull Pitch

Recs

1 Angiotech Pharmaceuticals, Inc. (USA) (ANPI)

Avatar Toddq34 (< 20) Submitted: 4/04/08 1:05 PM

Angiotech Pharmaceuticals, Inc. is a specialty pharmaceutical and medical device company that discovers, develops and markets technologies primarily focused on acute and surgical applications. The Company generates its revenue through the sales of medical products and components, as well as from roy...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 30 : 1 2 3 4 5 Next »

Recs 0 (ANPI) fburks (28.88) Submitted: 9/03/08 9:18 AM : Start Price: $1.62 ANPI Score: -41.41 First of all I have a very small position in this company. I based this position of my professional use of one of its products: Quills self retaining sutures. This is a great product that will probably grow in its use. I know this company has struggled with debt and reduced stent income, but I would still consider it a buy. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (ANPI) Fatiggy (< 20) Submitted: 8/01/08 2:11 PM : Start Price: $2.01 ANPI Score: -47.91 solid fundamentals Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (ANPI) TMFGoogly (29.23) Submitted: 7/22/08 10:37 PM : Start Price: $2.21 ANPI Score: -48.77 VII May 08 Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 1 (ANPI) Toddq34 (< 20) Submitted: 4/04/08 1:05 PM : Start Price: $2.85 ANPI Score: -48.44 Angiotech Pharmaceuticals, Inc. is a specialty pharmaceutical and medical device company that discovers, develops and markets technologies primarily focused on acute and surgical applications. The Company generates its revenue through the sales of medical products and components, as well as from royalties derived from sales by its partners of products utilizing certain of its own technologies. The Company operates in two segments: Pharmaceutical Technologies and Medical Products. The Pharmaceuticals Technologies segment includes royalty revenue and gross margin generated from out-licensing technology related to the drug-eluting stent and other technologies. As of December 31, 2007, the Company’s principal revenues in this segment come from royalties derived from sales by Boston Scientific Corporation (BSC) of TAXUS coronary stent systems incorporating the drug paclitaxel. The Medical Products segment includes revenues and gross margins of single use, specialty medical devices. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 1 (ANPI) JCSmiley (< 20) Submitted: 3/10/08 2:00 PM : Start Price: $3.03 ANPI Score: -49.89 Anyone willing to hang on to this one for 5+ years will be rewarded! :) Nice niche market. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 30 : 1 2 3 4 5 Next »

Wall Street

Results 1 - 4 of 4

picks per page. CHANGE Expand All Pitches Collapse All Pitches

Top Pick	Member Name	Member Rating	Start Date	Call	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Pitch
	TrackRBCCapMkts	84.11	04/30/08		NS	$3.34	-86.52%	-36.57%	-49.95
	TrackSoros	84.59	09/30/07		NS	$6.27	-92.82%	-42.00%	-50.83
	TrackPatDorsey	88.84	06/08/07		5Y	$6.85	-93.43%	-41.41%	-52.02
	TrackLehmanBros	73.44	11/20/06		NS	$8.35	-94.61%	-36.82%	-57.79

Results 1 - 4 of 4

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.